Cite
HARVARD Citation
N/A, . (2017). Romosozumab Lowers Vertebral Fracture Risk in Women With Postmenopausal Osteoporosis. Bone & joint. 23 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
N/A, . (2017). Romosozumab Lowers Vertebral Fracture Risk in Women With Postmenopausal Osteoporosis. Bone & joint. 23 (1), p. . [Online].